Expression of mir-7Scer\UAS.cLa under the control of Scer\GAL4Bx-MS1096 results in wing defects such as curving or blistering.
Expression of mir-7Scer\UAS.cLa under the control of Scer\GAL4sd-SG29.1 results in loss of wing margin, a reduction in wing size and thicker veins than normal.
Wings expressing mir-7Scer\UAS.cLa under the control of Scer\GAL4ptc-559.1 exhibit wing defects, including a distal wing notch and loss of the proximal L3/L4 domain.
mir-7Scer\UAS.cLa mutants (under the activation of Scer\GAL4ptc-559.1)exhibit wing notching and bristle tufting.
Expression of mir-7Scer\UAS.cLa under the control of Scer\GAL4dpp.blk1 results in a notched wing and a reduced L3-L4 intervein region. More generalised expression of mir-7Scer\UAS.cLa through Scer\GAL4Bx-MS1096 induces strong thickening of wing veins.
Scer\GAL4ptc-559.1, mir-7UAS.cLa has wing phenotype, non-suppressible by FHV\B2UAS.HM, Scer\GAL4ptc-559.1
Scer\GAL4ptc-559.1, mir-7UAS.cLa has wing phenotype, non-suppressible by NDV\B2UAS.HM, Scer\GAL4ptc-559.1
Scer\GAL4ptc-559.1, mir-7UAS.cLa has wing phenotype, non-suppressible by Scer\GAL4ptc-559.1/VV\E3LUAS.HM
Scer\GAL4ptc-559.1, mir-7UAS.cLa has wing phenotype, non-suppressible by Scer\GAL4ptc-559.1/TBSV\P19UAS.HM
Scer\GAL4ptc-559.1, mir-7UAS.cLa has wing phenotype, non-suppressible by Ivir\NS1UAS.HM, Scer\GAL4ptc-559.1
Expression of FHV\B2Scer\UAS.HM, Zzzz\B2Scer\UAS.HM, Zzzz\E3LScer\UAS.HM, Zzzz\p19Scer\UAS.HM or Ivir\NS1Scer\UAS.HM, under the control of Scer\GAL4ptc-559.1 does not inhibit the mir-7Scer\UAS.cLa overexpression wing-notching phenotype.